A Case of Septicaemic Melioidosis: Utility of Therapeutic Drug Monitoring and High-Dose Meropenem in Successful Management
Authors:
Open Access
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 36 (4) , 597-599
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?International Journal of Antimicrobial Agents, 2017
- A Nonparametric Pharmacokinetic Approach to Determine the Optimal Dosing Regimen for 30-Minute and 3-Hour Meropenem Infusions in Critically Ill PatientsTherapeutic Drug Monitoring, 2016
- Melioidosis: Evolving Concepts in Epidemiology, Pathogenesis, and TreatmentSeminars in Respiratory and Critical Care Medicine, 2015
- How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?BMC Infectious Diseases, 2014
- Clinical implications of antibiotic pharmacokinetic principles in the critically illIntensive Care Medicine, 2013
- Emerging clinico-epidemiological trends in melioidosis: analysis of 95 cases from western coastal IndiaInternational Journal of Infectious Diseases, 2012
- Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract InfectionsAntimicrobial Agents and Chemotherapy, 2007
- Management of melioidosisExpert Review of Anti-infective Therapy, 2006
- Antimicrobial Therapy in Critically Ill PatientsClinical Pharmacokinetics, 2005
- MelioidosisThe Lancet, 2003